Related Experiment Video
Updated: Aug 14, 2026
09:45
Construction of Model Lipid Membranes Incorporating G-protein Coupled Receptors (GPCRs)
Published on: February 5, 2022
Structural Dynamics of GLP-1 Analogues: Folding Energetics, Lipidation-Driven Assembly, and Aggregation Mechanisms
Angelo Santoro1, Marco Macis2, Anna Maria D'Ursi1
1Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy.
Molecules (Basel, Switzerland)
|August 13, 2026
Summary
Glucagon-like peptide-1 (GLP-1) analogues are key for metabolic diseases. Understanding their complex conformational dynamics, influenced by modifications and environment, is crucial for designing next-generation peptide therapeutics.
Area of Science:
- Biochemistry
- Pharmacology
- Chemical Engineering
Background:
- Glucagon-like peptide-1 (GLP-1) analogues are vital peptide therapeutics for metabolic diseases.
- These peptides exhibit dynamic conformational ensembles where folding, assembly, and aggregation are coupled.
- Existing therapeutic design often overlooks the intricate interplay of these processes.
Purpose of the Study:
- To investigate how sequence modifications and lipidation affect GLP-1 peptide conformation and pharmacokinetics.
- To explore the impact of environmental factors and manufacturing processes on peptide structural integrity.
- To address challenges in designing complex multi-agonist peptides and improve predictive modeling.
Main Methods:
- Analysis of sequence modifications (helix-promoting residues, backbone constraints) and their effect on helix-coil equilibrium.
- Investigation of lipidation effects on monomeric, oligomeric, and albumin-bound forms.
- Evaluation of environmental influences (ionic concentration, temperature) and manufacturing perturbations on conformation.
Main Results:
- Sequence modifications and lipidation were shown to modulate conformational stability and enhance pharmacokinetic properties.
- Environmental conditions and manufacturing processes can significantly impact the structural integrity of GLP-1 analogues.
- Increased sequence complexity in multi-agonist peptides broadens conformational diversity, challenging current design strategies.
Conclusions:
- Rational design of GLP-1 therapeutics requires managing conformational distributions across energy landscapes.
- Integrating biophysics, computation, and process science is essential for developing next-generation peptide drugs.
- A new framework focusing on conformational dynamics is proposed for effective therapeutic development.
Keywords:
GLP-1 analoguesaggregation mechanismlipidationmulti-agonist peptidespeptide foldingreversible oligomerizationMore Related Videos
Related Concept Videos
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:25Protein Folding
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
01:22Protein Folding
Overview
01:32Lipids as Anchors
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
01:24Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...